Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

TransCelerating and Crowdsourcing Pharma R&D

  • Broadcast in Business



Follow This Show

If you liked this show, you should follow Pharmaguy.

A Critical Shift in Drug Development in the Post-Blockbuster World

Guests Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly, Jerry Matczak, Community Manager for the Lilly Clinical Open Innovation Team, and Roland Andersson, Director for Accenture's Life Sciences R&D practice, discuss Lilly's Clinical Open Innovation project and the Transcelerate joint venture, both of which promote open source collaboration to speed development of new drugs.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled